FRI0061 Multi-biomarker disease activity (MBDA) score and the 12 individual biomarkers in early rheumatoid arthritis patients relate differentially to clinical response and radiographic progression: results from the swefot trial

Background In early rheumatoid arthritis (eRA), predictors of clinical response and of radiographic progression would be very useful for optimal targeting of available therapies. Individual biomarkers as well as combinations of biomarkers, such as the MBDA test, can be considered for these purposes....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of the rheumatic diseases 2013-06, Vol.72 (Suppl 3), p.A388-A389
Hauptverfasser:	Hambardzumyan, K., Saevarsdottir, S., Bolce, R., Forslind, K., Ernestam, S., Petersson, I., Geborek, P., Chernoff, D., Haney, D., Sasso, E. H., van Vollenhoven, R. F.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!